Incyte
INCY
493 hedge funds and large institutions have $13.9B invested in Incyte in 2021 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 205 increasing their positions, 155 reducing their positions, and 72 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 205 | Existing positions reduced: 155
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
0.88% less ownership
Funds ownership: 93.02% → 92.14% (-0.88%)
6% less call options, than puts
Call options by funds: $106M | Put options by funds: $112M
6% less funds holding
Funds holding: 522 → 493 (-29)
19% less capital invested
Capital invested by funds: $17.1B → $13.9B (-$3.19B)
29% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 72
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$219M |
| 2 |
D.E. Shaw & Co
New York
|
+$107M |
| 3 |
AC
Armistice Capital
New York
|
+$107M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$57.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$50.9M |
Top Sellers
INCY Hedge Fund Activity: Q3 2021 in Review
493 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2021, worth a combined $13.9B — down 19% from $17.1B a quarter earlier.
Sellers outnumbered buyers: 72 funds closed out of INCY and 51 opened new positions — a net loss of 21 holders — while 155 trimmed existing stakes and 205 added.
The largest buyer was Dodge & Cox, adding an estimated $219M. The largest seller was T. Rowe Price Associates, cutting an estimated $734M.
- 493 institutional investors held Incyte (INCY) as of Q3 2021, down from 522 in Q2 2021.
- Funds reported $13.9B of Incyte stock for Q3 2021, down 19% quarter-over-quarter.
- 51 funds opened new Incyte positions in Q3 2021 and 72 closed out, a net change of -21 holders.
- The largest Incyte buyer in Q3 2021 was Dodge & Cox, an estimated $219M added.
- The largest Incyte seller in Q3 2021 was T. Rowe Price Associates, an estimated $734M sold.
Based on aggregated 13F filings for Q3 2021.